Haleon PLC Sponsored ADR (HLN) to Issue Dividend of $0.13 on May 14th

Haleon PLC Sponsored ADR (NYSE:HLN) announced a dividend on Wednesday, February 25th. Shareholders of record on Friday, April 10th will be paid a dividend of 0.1307 per share on Thursday, May 14th. This represents a yield of 251.0%. The ex-dividend date of this dividend is Friday, April 10th.

Haleon has a dividend payout ratio of 20.4% meaning its dividend is sufficiently covered by earnings. Analysts expect Haleon to earn $0.49 per share next year, which means the company should continue to be able to cover its $0.11 annual dividend with an expected future payout ratio of 22.4%.

Haleon Stock Performance

NYSE HLN opened at $10.77 on Friday. Haleon has a 52-week low of $8.71 and a 52-week high of $11.42. The company has a fifty day moving average of $10.43 and a 200-day moving average of $9.80. The company has a market capitalization of $47.96 billion, a P/E ratio of 27.62 and a beta of 0.19. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.63 and a current ratio of 0.87.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on HLN shares. Jefferies Financial Group reissued a “buy” rating on shares of Haleon in a research note on Tuesday, January 20th. HSBC upgraded Haleon from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, January 21st. Weiss Ratings reissued a “hold (c)” rating on shares of Haleon in a research note on Thursday, January 22nd. Deutsche Bank Aktiengesellschaft cut Haleon from a “hold” rating to a “sell” rating in a research note on Monday, January 12th. Finally, Morgan Stanley reissued an “overweight” rating on shares of Haleon in a research report on Monday, December 15th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Haleon currently has a consensus rating of “Moderate Buy” and an average price target of $12.33.

Haleon Company Profile

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.